Letty Probasco is a Allentown, Pennsylvania based female rheumatologist who is specialized in Rheumatology. Active license number of Letty Probasco for Rheumatology is MT221341 in Pennsylvania. Letty Probasco treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Letty Probasco speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD
Gender:
Female
Practice Address:
1200 S Cedar Crest Blvd, Allentown, Pennsylvania, 18103-6202
Phone:
610-402-9116
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1144844077
NPI Enumeration Date:
06 Jun, 2020
NPI Last Update On:
19 Jun, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Letty Probasco are as mentioned below.
License Number
Specialization
State
Status
MT221341
Rheumatologist
Pennsylvania
Primary
MT221341
Internal Medicine
Pennsylvania
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1200 S Cedar Crest Blvd, Allentown, Pennsylvania
Zip:
18103-6202
Phone Number:
610-402-9116
Fax Number:
610-402-9610
Patients can reach Letty Probasco at 1200 S Cedar Crest Blvd, Allentown, Pennsylvania or can call to book an appointment on 610-402-9116. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.